Latest news in cancer
Zevorcabtagene autoleucel (Zevra-cel therapy) approved for R/R multiple myeloma
SHANGHAI, China, April 30, 2024, CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the...
After amazing growth of CAR T-Cell therapy: what’s next?
CAR T-cell therapy has rapidly transformed cancer treatment by reprogramming a patient's T-cells to attack cancer cells, demonstrating remarkable success in...
Lutetium Lu 177 dotatate is approved by USFDA for pediatric patients 12 years and older with GEP-NETS
Lutetium Lu 177 dotatate, a groundbreaking treatment, has recently received approval from the US Food and Drug Administration (FDA) for pediatric patients,...
Nogapendekin alfa inbakicept-pmln is approved by the USFDA for BCG-unresponsive non-muscle invasive bladder cancer
"Nogapendekin Alfa Inbakicept-PMLN, a novel immunotherapy, shows promise in treating bladder cancer when combined with BCG therapy. This innovative approach...
Alectinib has been approved by the USFDA as adjuvant treatment for ALK-positive non-small cell lung cancer
The FDA's recent approval of alectinib marks a significant advancement in the treatment landscape for ALK-positive non-small cell lung cancer (NSCLC). As an...
NMPA approves zevorcabtagene autoleucel CAR T Cell therapy for R/R multiple myeloma
Zevor-Cel therapy Chinese regulators have approved zevorcabtagene autoleucel (zevor-cel; CT053), an autologous CAR T-cell therapy, for the treatment of adult...
Understanding BCMA: A Revolutionary Target in Cancer Treatment
Introduction In the ever-evolving realm of oncological treatment, scientists persistently seek out unconventional targets that can amplify the effectiveness of...
Human-Based CAR T Cell Therapy: Breakthroughs and Challenges
Human-based CAR T-cell therapy revolutionizes cancer treatment by genetically modifying a patient's own immune cells to target and destroy cancer cells. By...
Understanding Cytokine Release Syndrome: Causes, Symptoms, and Treatment
Cytokine Release Syndrome (CRS) is an immune system reaction often triggered by certain treatments like immunotherapy or CAR-T cell therapy. It involves an...
Role of paramedics in the success of CAR T Cell therapy
Paramedics play a crucial role in the success of CAR T-cell therapy by ensuring seamless patient care throughout the treatment process. They provide vital...
How Targeted Therapy is Revolutionizing Advanced Cancer Treatment?
In the field of oncology, the emergence of targeted therapy has revolutionized the treatment landscape for advanced cancers. Unlike conventional chemotherapy,...
Utilizing Immunotherapy to Treat Late-Stage Cancers
Introduction Immunotherapy has become a groundbreaking method in cancer treatment, especially for advanced-stage cancer treatments that have...
Need help? Our team is ready to assist you.
We wish a speedy recovery of your dear and near one.